SD Passik, J Messina, A Golsorkhi… - Journal of pain and symptom …, 2011 - Elsevier Data from opioid-tolerant patients participating in clinical studies of fentanyl buccal tablet (FBT) for breakthrough pain (up to 18 months of clinical study case-report forms) were retrospectively reviewed and coded for abuse, overdose, and aberrant behavior. Aberrant behaviors ... Cited by 6 - Related articles - All 6 versions
S Mercadante, P Ferrera, C Adile… - Journal of Pain and …, 2011 - Elsevier Twelve patients who were receiving opioids for background analgesia at doses equivalent to more than 500 mg of oral morphine and had adequately controlled pain were prospectively recruited. BTcP was treated with proportional doses of FBT: patients receiving 600 mg of ... Related articles - All 3 versions
DL Saunders, J Messina, M Darwish… - The Journal of …, 2011 - jcp.sagepub.com It is generally accepted that the relative potency of opioids can be calculated to allow rational dose con- versions. The potency of an opioid analgesic is typi- cally expressed relative to intravenous (IV) morphine and can be determined using experimental clinical pharmacology models ... Cited by 1 - Related articles - All 3 versions
C Juliano, M Cossu, MT Rota… - Drug development …, 2011 - informahealthcare.com There is growing evidence that a large proportion of upper digestive tract tumors are ascribable to heavy alcohol drinking and tobacco consumption. The cancer-promoting action of ethanol is mediated by acetaldehyde, its first metabolite, also derived from the bacterial oxidation ... Related articles - All 3 versions
SR Nalamachu, A Narayana… - … Medical Research & …, 2011 - informahealthcare.com Of 1160 patients who received ≥1 dose of FBT, 83% achieved a successful dose, ranging from 100 to 800 μg, mostly at 600 or 800 μg. Not all of the patients included in this analysis were enrolled in long-term studies and 156 (13%) patients were still receiving ongoing treatment when ... Related articles - All 5 versions